FindTrial
Sign In

Prospective comparative study on Endoscopic Ultrasonography (EUS) – Guided Fine-Needle Aspiration (FNA) using the 22G Conventional needles or Procore Needles without immediate on-site cytopathologic examination

Prospective comparative study on Endoscopic Ultrasonography (EUS) – Guided Fine-Needle Aspiration (FNA) using the 22G Conventional needles or Procore Needles without immediate on-site cytopathologic examination

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TTRCC-12002136
Enrollment
Unknown
Registered
2012-05-01
Start date
2012-05-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neoplasm

Interventions

Two groups:EUS-FNA with 22G Procore needle vs EUS-FNA with 22G Conventional needle for 30 to 60 min

Sponsors

Nil
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Consecutive patients (aged between 18 and 80 years) referred for EUS-guided tissue acquisition for evaluating intestinal or extra-intestinal mass lesions more than 2cm in the largest diameter would be included.

Exclusion criteria

Exclusion criteria: Patients with coagulopathy, previous history of upper gastrointestinal surgery, contraindications for conscious sedation, pregnancy and those who cannot provide informed consent would be excluded.

Design outcomes

Primary

MeasureTime frame
proportion of patients with cyto-histopathology confirmed neoplasms diagnosed by EUS-guided FNA;—

Secondary

MeasureTime frame
sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and diagnostic accuracy.;—

Countries

China

Contacts

Public ContactCharing Chong
chongcn@surgery.cuhk.edu.hk+86 2632 1411

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026